DK0871438T3 - Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation - Google Patents
Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammationInfo
- Publication number
- DK0871438T3 DK0871438T3 DK96920846T DK96920846T DK0871438T3 DK 0871438 T3 DK0871438 T3 DK 0871438T3 DK 96920846 T DK96920846 T DK 96920846T DK 96920846 T DK96920846 T DK 96920846T DK 0871438 T3 DK0871438 T3 DK 0871438T3
- Authority
- DK
- Denmark
- Prior art keywords
- inflammation
- medicament
- manufacture
- treatment
- hydroxy acids
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 229940061720 alpha hydroxy acid Drugs 0.000 title 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI953090A FI953090A0 (fi) | 1995-06-21 | 1995-06-21 | Foerfarande foer framstaellning av alfahydroxidsyra eller en produkt som innehaoller den, och dess onvaendning samt vaordmetod |
| PCT/FI1996/000363 WO1997000676A1 (fr) | 1995-06-21 | 1996-06-20 | Composes antimicrobiens et anti-inflammatoires |
| FI962602A FI119543B (fi) | 1995-06-21 | 1996-06-20 | Alfa-hydroksihappojen käyttö valmistettaessa lääkettä tulehduksen hoitoon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0871438T3 true DK0871438T3 (da) | 2008-06-30 |
Family
ID=26159986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96920846T DK0871438T3 (da) | 1995-06-21 | 1996-06-20 | Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0871438B1 (fr) |
| AU (1) | AU6225896A (fr) |
| DE (1) | DE69637449T2 (fr) |
| DK (1) | DK0871438T3 (fr) |
| FI (1) | FI119543B (fr) |
| WO (1) | WO1997000676A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214363B1 (en) | 1997-11-12 | 2001-04-10 | The Procter & Gamble Company | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria |
| US6210695B1 (en) | 1997-06-04 | 2001-04-03 | The Procter & Gamble Company | Leave-on antimicrobial compositions |
| US6183757B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing |
| US6284259B1 (en) | 1997-11-12 | 2001-09-04 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria |
| US6287577B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
| US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
| US6190674B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Liquid antimicrobial cleansing compositions |
| US6197315B1 (en) | 1997-06-04 | 2001-03-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
| US6183763B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
| US6190675B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
| US6287583B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
| FR2810547B1 (fr) * | 2000-06-22 | 2004-01-30 | Pasteur Institut | Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif |
| FR2863168A1 (fr) * | 2003-12-04 | 2005-06-10 | Centre Nat Rech Scient | Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone. |
| WO2020227420A1 (fr) * | 2019-05-06 | 2020-11-12 | The General Hospital Corporation | Surveillance et modification du microbiome intestinal dans une maladie |
| FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
| CN117919216A (zh) * | 2024-01-29 | 2024-04-26 | 中国药科大学 | 2-羟基-3-甲基丁酸在制备预防和/或治疗动脉粥样硬化的药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
-
1996
- 1996-06-20 DE DE69637449T patent/DE69637449T2/de not_active Expired - Lifetime
- 1996-06-20 EP EP96920846A patent/EP0871438B1/fr not_active Expired - Lifetime
- 1996-06-20 FI FI962602A patent/FI119543B/fi not_active IP Right Cessation
- 1996-06-20 DK DK96920846T patent/DK0871438T3/da active
- 1996-06-20 AU AU62258/96A patent/AU6225896A/en not_active Abandoned
- 1996-06-20 WO PCT/FI1996/000363 patent/WO1997000676A1/fr active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FI962602A0 (fi) | 1996-06-20 |
| AU6225896A (en) | 1997-01-22 |
| FI962602L (fi) | 1996-12-22 |
| DE69637449D1 (de) | 2008-04-10 |
| WO1997000676A1 (fr) | 1997-01-09 |
| DE69637449T2 (de) | 2009-03-12 |
| EP0871438B1 (fr) | 2008-02-27 |
| EP0871438A1 (fr) | 1998-10-21 |
| FI119543B (fi) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| FI973292A7 (fi) | Substituoituja isoksatsoleja tulehduksen hoitamiseksi | |
| DK0871438T3 (da) | Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation | |
| FI962249A7 (fi) | Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten | |
| DE122005000024I2 (de) | Darifenacin enthaltende Pharmazeutische zuberreitungen | |
| EE03512B1 (et) | Epinastiin kasutamiseks valude ravis | |
| FI973868A0 (fi) | D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyperparatyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa | |
| DK0730864T3 (da) | Lægemiddel til behandling af inflammatoriske hjertesygdomme | |
| FI961630A7 (fi) | Terapeuttisia aineita | |
| AU2027695A (en) | Pharmaceutical composition for treating stoma-peripheral inflammation diseases | |
| EP0820286A4 (fr) | Traitement d'inflammations oculaires | |
| PT777457E (pt) | A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses | |
| IL119459A0 (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
| NO984759D0 (no) | Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi | |
| NO975660D0 (no) | Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi | |
| GB2319729B (en) | A film for topical use in the treatment of wounds | |
| FR2758003B1 (fr) | Traitement anti-reflet de surfaces reflectives | |
| EP0765661A3 (fr) | Utilisation de l'acide docosahexaénique pour la fabrication d'un médicament pour le traitement de la glomérulonephrite | |
| EE9700235A (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
| DK0866699T3 (da) | Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi | |
| NO990949D0 (no) | Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS | |
| LV11966A (lv) | Pretiekaisumu lidzeklis arigai lietosanai | |
| NO986053L (no) | Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis | |
| NO975554D0 (no) | Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon | |
| ZA944671B (en) | Medicaments for the treatment of inflammatory diseases |